Pitcairn Company »

Tg Therapeutics shares owned by Pitcairn Company

Quarter-by-quarter ownership of Tg Therapeutics (TGTX) shares owned by Pitcairn Company from 13F filings

Historical chart of Pitcairn Company investment in Tg Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tg Therapeutics held by Pitcairn Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tg Therapeutics by Pitcairn Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $233k 14k 17.08
2023-09-30 $113k 14k 8.36
2023-06-30 $246k 9.9k 24.84